Publication:
And fibrinolysis became pharmacoinvasive

Thumbnail Image

Files

AndFibrinolysisBecamePharmacoinvasive_2020.pdf (387.89 KB)
Identifiers
URI: http://hdl.handle.net/20.500.12105/9470
ISSN: 0195-668X
DOI: 10.1093/eurheartj/ehz716

Publication date

2020-02-14

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

Oxford University Press
Metrics
Google Scholar
Export
MarcXML METS

Research Projects

Organizational Units

Journal Issue

Abstract

This editorial refers to ‘16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction’†, by P.G. Thrane et al.

Description

Keywords

MeSH Terms

DeCS Terms

Bibliographic citation

Eur Heart J. 2020; 51(7):855-7

Collections

Grupos de investigación

Publisher version

https://doi.org/10.1093/eurheartj/ehz716

Related dataset

Related publication

Document type

journal article